CD8 + T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Chyu, Kuang Yuh ^a   Zhao, Xiaoning ^a   Dimayuga, Paul C ^a   Zhou, Jianchang ^a   Li, Xiaojun ^a   Yano, Juliana ^a   Lio, Wai Man ^a   Chan, Lai Fan ^a   Kirzner, Jonathan ^a   Trinidad, Portia ^a   Cercek, Bojan ^a   Shah, Prediman K ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN E; BCR ABL PROTEIN; ANTIGEN; PEPTIDE FRAGMENT; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; HEART PROTECTION; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MALE; MICROSCOPY; MORPHOMETRICS; MOUSE; NONHUMAN; PHENOTYPE; ADOPTIVE TRANSFER; ANIMAL; ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; IMMUNOLOGY; MOUSE MUTANT; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HYPERCHOLESTEROLEMIA; IMMUNIZATION; MICE; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PROTECTIVE AGENTS;

EID: 84863041199     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030780     Document Type: Article

References (40)

1. Shah PK, Chyu KY, Fredrikson GN, Nilsson J, (2005) Immunomodulation of atherosclerosis with a vaccine. Nat Clin Pract Cardiovasc Med 2: 639-646.
2. Hansson GK, Libby P, Schonbeck U, Yan ZQ, (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91: 281-291.
3. Chyu KY, Zhao X, Reyes OS, Babbidge SM, Dimayuga PC, et al. (2005) Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice. Biochem Biophys Res Commun 338: 1982-1989.
4. Fredrikson GN, Soderberg I, Lindholm M, Dimayuga P, Chyu KY, et al. (2003) Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences. Arterioscler Thromb Vasc Biol 23: 879-884.
5. Fredrikson GN, Andersson L, Soderberg I, Dimayuga P, Chyu KY, et al. (2005) Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression. Autoimmunity 38: 171-179.
6. Fredrikson GN, Bjorkbacka H, Soderberg I, Ljungcrantz I, Nilsson J, (2008) Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies. J Intern Med pp. 1-8.
7. Klingenberg R, Lebens M, Hermansson A, Fredrikson GN, Strodthoff D, et al. (2010) Intranasal Immunization With an Apolipoprotein B-100 Fusion Protein Induces Antigen-Specific Regulatory T Cells and Reduces Atherosclerosis. Arterioscler Thromb Vasc Biol 30: 946-952.
8. Wigren M, Kolbus D, Duner P, Ljungcrantz I, Soderberg I, et al. (2011) Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J Intern Med 269: 546-556.
9. Palinski W, Miller E, Witztum JL, (1995) Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci U S A 92: 821-825.
10. Ameli S, Hultgardh-Nilsson A, Regnstrom J, Calara F, Yano J, et al. (1996) Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol 16: 1074-1079.
11. Freigang S, Horkko S, Miller E, Witztum JL, Palinski W, (1998) Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol 18: 1972-1982.
12. George J, Afek A, Gilburd B, Levkovitz H, Shaish A, et al. (1998) Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis 138: 147-152.
13. Zhou X, Caligiuri G, Hamsten A, Lefvert AK, Hansson GK, (2001) LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler Thromb Vasc Biol 21: 108-114.
14. Chyu KY, Reyes OS, Zhao X, Yano J, Dimayuga P, et al. (2004) Timing affects the efficacy of LDL immunization on atherosclerotic lesions in apo E (-/-) mice. Atherosclerosis 176: 27-35.
15. Zhou X, Robertson AK, Rudling M, Parini P, Hansson GK, (2005) Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res 96: 427-434.
16. Zhou X, Nicoletti A, Elhage R, Hansson GK, (2000) Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102: 2919-2922.
17. Zhou X, Robertson AK, Hjerpe C, Hansson GK, (2006) Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol 26: 864-870.
18. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, et al. (2006) Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 12: 178-180.
19. Mor A, Planer D, Luboshits G, Afek A, Metzger S, et al. (2007) Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 27: 893-900.
20. Roselaar SE, Kakkanathu PX, Daugherty A, (1996) Lymphocyte populations in atherosclerotic lesions of apoE-/- and LDL receptor-/- mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 16: 1013-1018.
21. Zhou X, Stemme S, Hansson GK, (1996) Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 149: 359-366.
22. Fyfe AI, Qiao JH, Lusis AJ, (1994) Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. J Clin Invest 94: 2516-2520.
23. Kolbus D, Ramos OH, Berg KE, Persson J, Wigren M, et al. (2010) CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe(/) mice. BMC Immunol 11: 58.
24. Dimayuga P, Chyu KY, Kirzner J, Yano J, Zhao XN, et al. (2011) Enhanced neointima formation following arterial injury in immune deficient Rag-1-/- mice is attenuated by adoptive transfer of CD8+ T cells. PLoS ONE 6: e20214.
25. Bobryshev YV, Taksir T, Lord RS, Freeman MW, (2001) Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice. Histol Histopathol 16: 801-808.
26. Niessner A, Weyand CM, (2009) Dendritic cells in atherosclerotic disease. Clin Immunol 134: 25-32.
27. Paulson KE, Zhu SN, Chen M, Nurmohamed S, Jongstra-Bilen J, et al. (2010) Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res 106: 383-390.
28. Liu P, Yu YR, Spencer JA, Johnson AE, Vallanat CT, et al. (2008) CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler Thromb Vasc Biol 28: 243-250.
29. Wu H, Gower RM, Wang H, Perrard XY, Ma R, et al. (2009) Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119: 2708-2717.
30. Sakamoto N, Tsuji K, Muul LM, Lawler AM, Petricoin EF, et al. (2007) Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood 110: 501-508.
31. van den Elzen P, Garg S, Leon L, Brigl M, Leadbetter EA, et al. (2005) Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437: 906-910.
32. Fredrikson GN, Hedblad B, Berglund G, Alm R, Ares M, et al. (2003) Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease. Arterioscler Thromb Vasc Biol 23: 872-878.
33. Schiopu A, Bengtsson J, Soderberg I, Janciauskiene S, Lindgren S, et al. (2004) Recombinant Human Antibodies Against Aldehyde-Modified Apolipoprotein B-100 Peptide Sequences Inhibit Atherosclerosis. Circulation 110: 2047-2052.
34. Sjogren P, Fredrikson GN, Samnegard A, Ericsson CG, Ohrvik J, et al. (2008) High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction. Eur Heart J 29: 2218-2226.
35. Dimayuga P, Cercek B, Oguchi S, Fredrikson GN, Yano J, et al. (2002) Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in Rag-1 knockout mice. Arterioscler Thromb Vasc Biol 22: 644-649.
36. Caligiuri G, Nicoletti A, Poirier B, Hansson GK, (2002) Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 109: 745-753.
37. Yang K, Li D, Luo M, Hu Y, (2006) Generation of HSP60-specific regulatory T cell and effect on atherosclerosis. Cell Immunol 243: 90-95.
38. Yang GX, Lian ZX, Chuang YH, Moritoki Y, Lan RY, et al. (2008) Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 47: 1974-1982.
39. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.
40. Lecoeur H, Fevrier M, Garcia S, Riviere Y, Gougeon ML, (2001) A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 253: 177-187.